SirYus technology targets high-growth segments of the in vitro diagnostics markets, and aims to provide a fully automated multiplex diagnostic tool answering the needs of healthcare professionals.

The in vitro diagnostics market is evaluated at 70 billion dollars a year and grows at a 5% rate worldwide. 

SirYus technology presently targets the transplantation, transfusion, Infectious diseases and microbiome markets, that represent together about 40 % of the total valuation.

A concentrated market

15 companies account for 90 % of the In Vitro Diagnotics market, providing large opportunities for the SirYus technology licencing.

A high-growth market

US and Europe markets grow at a constant rate of 5 % while Asian markets demonstrate very high growth (+ 25 % in China for example).